Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Stuart Knechtle
Duke University, Department: Surgery
Should you be removed from our database? Contact us at [email protected]. Read more below.
Bristol-Myers Squibb
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)
PI owns stock (received through an inheritance) in BMS. One of the drugs being used in the study is a BMS drug.
The Risks and Opportunities of Homeostatic Repopulation
PROJECT NARRATIVE Transplantation is a cure for many end stage organ diseases, but the immunosuppression required to prevent graft rejection carries with it several side effects that can impact patient health. This program seeks to use preclinical models to test new therapeutic strategies for use in transplantation, with the goals of improving tolerance, minimizing graft rejection, preserving protective immunity, and maximizing patient health.
Filed on January 23, 2019.
Tell us what you know about Stuart Knechtle's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Stuart Knechtle”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Stuart Knechtle | Emory University | Conflict of Interest | Bristol -Myers Squibb | >$600,000 |
| Stuart Knechtle | Emory University | Conflict of Interest | Bristol-Myers Squibb | >$600,000 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.